STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $278,947 | +46.5% | 33,487 | +62.3% | 0.00% | – |
| Q4 2022 | $190,424 | -14.2% | 20,631 | +19.1% | 0.00% | – |
| Q3 2022 | $222,000 | -71.0% | 17,327 | -12.1% | 0.00% | – |
| Q1 2021 | $766,000 | +165.1% | 19,718 | +322.7% | 0.00% | – |
| Q4 2020 | $289,000 | +38.3% | 4,665 | -25.4% | 0.00% | – |
| Q3 2020 | $209,000 | -14.7% | 6,253 | -39.3% | 0.00% | – |
| Q2 2020 | $245,000 | – | 10,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $9,991,000 | 2.07% |
| RTW INVESTMENTS, LP | 3,644,248 | $122,665,000 | 1.85% |
| Cormorant Asset Management, LP | 1,278,276 | $43,027,000 | 1.46% |
| Redmile Group, LLC | 2,458,558 | $82,755,000 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 233,135 | $7,847,000 | 0.53% |
| Birchview Capital, LP | 15,000 | $505,000 | 0.30% |
| Perceptive Advisors | 1,343,956 | $45,238,000 | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 1,245,956 | $41,939,000 | 0.21% |
| Artal Group S.A. | 250,000 | $8,415,000 | 0.17% |
| Casdin Capital, LLC | 120,000 | $4,039,000 | 0.10% |